J.P. Morgan Healthcare Confab Live Blog: Day Three

 

SAN FRANCISCO (TheStreet) -- Here we are, the final live blog of the J.P. Morgan Healthcare Conference 2014. It's Wednesday, hump day, featuring presentations from MannKind (MNKD), Keryx Pharma  (KERX), Alexion Pharma (ALXN), Geron (GERN) and Sarepta Therapeutics (SRPT).

By now, you know the drill. I will be posting news updates and analysis throughout the day, live from the presentation rooms and breakout (Q&A) sessions. You can also follow me on Twitter, my handle is @adamfeuerstein. Your best bet is to check back into the live blog several times throughout the day. Feel free to ping me with questions and comments. I'll do my best to respond and keep the live blog as interactive as possible.

Here's my schedule for the day, preliminary, subject to change. All times Eastern.

MannKind 10:30 am
Keryx 11:30 am
Alexion 12:30 pm
Newlink Genetics (NLNK) 1 pm
Bluebird Bio  (BLUE) 1:30 pm
Geron 4:30 pm
Exelixis (EXEL) 5 pm
Morphosys 7 pm
Sarepta Therapeutics 7:30 pm

Sleep: 8 pm until well into tomorrow.


-- Reported by Adam Feuerstein in San Francisco.  

Follow Adam Feuerstein on Twitter.

Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback; click here to send him an email.

More from Investing

Four Stocks Poised for Big Gains: Cramer's 'Off the Charts'

Four Stocks Poised for Big Gains: Cramer's 'Off the Charts'

3 Great Stocks for Retirees to Own

3 Great Stocks for Retirees to Own

9 Stocks Goldman Sachs Thinks Will Blow Wall Street's Performance Away in 2019

9 Stocks Goldman Sachs Thinks Will Blow Wall Street's Performance Away in 2019

Jim Cramer's Investing Rule #4: Buy Damaged Stocks, Not Damaged Companies

Jim Cramer's Investing Rule #4: Buy Damaged Stocks, Not Damaged Companies

Jim Cramer's Investing Rule #3: Don't Buy Stocks All at Once

Jim Cramer's Investing Rule #3: Don't Buy Stocks All at Once